Sodium-Glucose Transport Proteins, antagonists & inhibitors

Name
Sodium-Glucose Transport Proteins, antagonists & inhibitors
Accession Number
DBCAT001788
Description

Not Available

Drugs
DrugDrug Description
DapagliflozinA sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus.
BexagliflozinA sodium-glucose co-transporter 2 inhibitor used to improve glycemic control in patients with type 2 diabetes mellitus.
Drugs & Drug Targets
DrugTargetType
DapagliflozinSodium/glucose cotransporter 2target
DapagliflozinCytochrome P450 1A1enzyme
DapagliflozinCytochrome P450 1A2enzyme
DapagliflozinCytochrome P450 2A6enzyme
DapagliflozinCytochrome P450 2C9enzyme
DapagliflozinCytochrome P450 2D6enzyme
DapagliflozinCytochrome P450 3A4enzyme
DapagliflozinUDP-glucuronosyltransferase 1-9enzyme
DapagliflozinUDP-glucuronosyltransferase 2B4enzyme
DapagliflozinUDP-glucuronosyltransferase 2B7enzyme
DapagliflozinP-glycoprotein 1transporter
BexagliflozinUDP-glucuronosyltransferase 1-9enzyme
BexagliflozinCytochrome P450 3A4enzyme
BexagliflozinCytochrome P450 2C8enzyme
BexagliflozinCytochrome P450 2D6enzyme
BexagliflozinUDP-glucuronosyltransferase 1-1enzyme
BexagliflozinSodium/glucose cotransporter 2target
BexagliflozinP-glycoprotein 1transporter